Drugs / G-CSF (pegfilgrastim)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01840579 Background | Apr 2013 → Feb 2020 | non-small cell lung carcinoma, small cell lung carcinoma | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF (pegfilgrastim) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01840579 ↗ |